Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Catalyst Pharmaceuticals Inc. (CPRX)

NASDAQ: CPRX · Pharmaceutical Preparations · Coral Gables, FL

Our rating: Positive

Positive reaffirmed at $31.38, moderate conviction, June 18, 2026.

Breaks if: The positive call would be disproved if reported revenue growth falls below 10% on a trailing twelve-month basis at any results print through June 2027, or if net margin drops below 28% in two consecutive reported quarters — either would suggest the commercial franchise is decelerating faster than today's multiple assumes.

Key figures

Market value$3.9B
Revenue, last 12 months$597M
Net income, last 12 months$221M
Free cash flow, last 12 months$208M
Price to earnings17.4×
Free cash flow yield5.4%
Dividend yield0.0%
Operating margin44.8%
Return on equity24.5%
Beta to the S&P 5000.85
Volatility, annualized36.4%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
March 31, 2026$149M5.6%$0.50$60M
December 31, 2025$153M7.6%$0.41$45M
September 30, 2025$148M15.3%$0.42$32M
June 30, 2025$147M19.4%$0.41$71M
March 31, 2025$141M43.6%$0.45$60M
December 31, 2024$142M28.3%$0.44$71M
September 30, 2024$129M25.3%$0.35$73M
June 30, 2024$123M23.2%$0.33$64M

6 ledger entries and 54 corporate events on record. Share price as of July 16, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.